Tremelimumab for patients with chemotherapy-resistant advanced malignant mesothelioma: an open-label, single-arm, phase 2 trial

Autor: Calabrò, Luana, Morra, Aldo, Fonsatti, Ester, Cutaia, Ornella, Amato, Giovanni, Giannarelli, Diana, Di Giacomo, Anna Maria, Danielli, Riccardo, Altomonte, Maresa, Mutti, Luciano, Maio, Michele
Zdroj: In The Lancet Oncology October 2013 14(11):1104-1111
Databáze: ScienceDirect